Niigata University Medical & Dental Hospital

This study is testing the immunotherapy drug pembrolizumab for women with advanced or recurrent ovarian squamous cell carcinoma that cannot be removed by surgery. The goal is to see if the drug can shrink tumors and help patients live longer. The trial will enroll 21 participants…